The risk factors and incidence of major infectious diseases in patients with ankylosing spondylitis receiving tumor necrosis factor inhibitors

References

• Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3(9):745–56.
   PubMed Web of Science ®Google Scholar
• Sullivan KE. Regulation of inflammation. IR. 2003;27(2-3):529–38.
   Google Scholar
• Sepriano A, Regel A, van der Heijde D, Braun J, Baraliakos X, Landewe R, et al. Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis. RMD Open. 2017;3(1):e000396.
   PubMed Web of Science ®Google Scholar
• van der Heijde D, Ramiro S, Landewe R, Baraliakos X, Van den Bosch F, Sepriano A, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978–91.
   PubMed Web of Science ®Google Scholar
• Kim JA, Yoon S, Kim LY, Kim DS. Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci. 2017;32(5):718–28.
   PubMed Web of Science ®Google Scholar
• Kim L, Kim JA, Kim S. A guide for the utilization of health insurance review and assessment service national patient samples. Epidemiol Health. 2014;36:e2014008
   PubMedGoogle Scholar
• Seong JM, Choi NK, Shin JY, Chang Y, Kim YJ, Lee J, et al. Differential cardiovascular outcomes after dipeptidyl peptidase-4 inhibitor, sulfonylurea, and pioglitazone therapy, all in combination with metformin, for type 2 diabetes: a population-based cohort study. PLOS One. 2015;10(5):e0124287.
   PubMed Web of Science ®Google Scholar
• Shin JY, Park MJ, Lee SH, Choi SH, Kim MH, Choi NK, et al. Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study. BMJ. 2015;351:h3517.
   PubMedGoogle Scholar
• Lee MY, Shin JY, Park SY, Kim D, Cha HS, Lee EK. Persistence of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: an analysis of the South Korean National Health Insurance Database. Semin Arthritis Rheum. 2018;47(4):485–91.
   PubMed Web of Science ®Google Scholar
• Bonafede M, Fox KM, Watson C, Princic N, Gandra SR. Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings. Adv Ther. 2012;29(8):664–74.
   PubMed Web of Science ®Google Scholar
• Park JS, Jang HD, Hong JY, Park YS, Han K, Suh SW, et al. Impact of ankylosing spondylitis on depression: a nationwide cohort study. Sci Rep. 2019;9(1):6736.
   PubMedGoogle Scholar
• Wijnands JM, Kingwell E, Zhu F, Zhao Y, Fisk JD, Evans C, et al. Infection-related health care utilization among people with and without multiple sclerosis. Mult Scler. 2017;23(11):1506–16.
   PubMed Web of Science ®Google Scholar
• Trotter CL, Stuart JM, George R, Miller E. Increasing hospital admissions for pneumonia, England. Emerg Infect Dis. 2008;14(5):727–33.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Wahlstrom J, Grunewald J, Ekbom A, Montgomery SM. Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax. 2007;62(1):23–8.
   PubMedGoogle Scholar
• Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes zoster and its complications in Germany, 2005–2009. J Infect. 2015;70(2):178–86.
   PubMed Web of Science ®Google Scholar
• Fouque-Aubert A, Jette-Paulin L, Combescure C, Basch A, Tebib J, Gossec L. Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials. Ann Rheum Dis. 2010;69(10):1756–61.
   PubMed Web of Science ®Google Scholar
• Wallis D, Thavaneswaran A, Haroon N, Ayearst R, Inman RD. Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort. Rheumatology. 2015;54(1):152–6.
   PubMed Web of Science ®Google Scholar
• Moura CS, Rahme E, Maksymowych WP, Abrahamowicz M, Bessette L, Bernatsky S. Use of disease-modifying anti-rheumatic or anti-tumour necrosis factor drugs and risk of hospitalized infection in ankylosing spondylitis. Scand J Rheumatol. 2019;48(2):121–127.
   PubMed Web of Science ®Google Scholar
• Lim CH, Chen HH, Chen YH, Chen DY, Huang WN, Tsai JJ, et al. The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: a 15-year real world experience in Taiwan. PLOS One. 2017;12(6):e0178035.
   PubMed Web of Science ®Google Scholar
• Goldman DL. The other side of the coin: anti-inflammatory antibody therapy for infectious diseases. Infect Immun. 2019;88:e00844–19.
   Web of Science ®Google Scholar
• Heo JY, Seo YB, Choi WS, Lee J, Yoon JG, Lee SN, et al. Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: catchment population-based analysis. PLOS One. 2018;13(3):e0194598.
   PubMed Web of Science ®Google Scholar
• Singh JA, Saag KG, Bridges SL, Jr., Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2016;68(1):1–26.
   PubMed Web of Science ®Google Scholar
• Jung SM, Ju JH, Park MS, Kwok SK, Park KS, Kim HY, et al. Risk of tuberculosis in patients treated with anti-tumor necrosis factor therapy: a nationwide study in South Korea, a country with an intermediate tuberculosis burden. Int J Rheum Dis. 2015;18(3):323–30.
   PubMed Web of Science ®Google Scholar
• Kim JH, Won S, Choi CB, Sung YK, Song GG, Bae SC. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents. Int J Rheum Dis. 2015;18(3):315–22.
   PubMed Web of Science ®Google Scholar
• Kim EM, Uhm WS, Bae SC, Yoo DH, Kim TH. Incidence of tuberculosis among Korean patients with ankylosing spondylitis who are taking tumor necrosis factor blockers. J Rheumatol. 2011;38(10):2218–23.
   PubMed Web of Science ®Google Scholar
• Wallis RS. Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis. 2008;8(10):601–11.
   PubMed Web of Science ®Google Scholar
• Lim DH, Kim YJ, Kim SO, Hong S, Lee CK, Yoo B, et al. The risk of herpes zoster in patients with ankylosing spondylitis: Analysis of the Korean National Health Insurance Service – sample cohort database. Mod Rheumatol. 2018;28(1):168–73.
   PubMed Web of Science ®Google Scholar
• Kim TJ, Lee S, Joo KB, Park DJ, Park YW, Lee SS, et al. The presence of peripheral arthritis delays spinal radiographic progression in ankylosing spondylitis: Observation Study of the Korean Spondyloarthropathy Registry. Rheumatology. 2014;53(8):1404–8.
   PubMed Web of Science ®Google Scholar